Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization

What happened: Micron Biomedical appointed Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization, reporting to the CEO. Why it matters: The company framed the hire as part of its transition from a platform technology to a commercial products company, citing his experience turning drug delivery technologies into medicines at Lilly and AstraZeneca. The appointment follows recent federal contracts and the opening of a commercial-scale manufacturing site in Alpharetta, Georgia. Market: -1.1% today ($170.08), -6.2% YTD, 1.0x vol — as of 22:46 UTC

Micron Biomedical appointed Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization, reporting to the CEO.

The company framed the hire as part of its transition from a platform technology to a commercial products company, citing his experience turning drug delivery technologies into medicines at Lilly and AstraZeneca. The appointment follows recent federal contracts and the opening of a commercial-scale manufacturing site in Alpharetta, Georgia. Market: -1.1% today ($170.08), -6.2% YTD, 1.0x vol — as of 22:46 UTC